GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrobiosystems Co Ltd (SZSE:301080) » Definitions » Capex-to-Operating-Income

Acrobiosystems Co (SZSE:301080) Capex-to-Operating-Income : 0.17 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acrobiosystems Co Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Acrobiosystems Co's Capital Expenditure for the three months ended in Mar. 2024 was ¥-4.78 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥27.53 Mil.

Hence, Acrobiosystems Co's Capex-to-Operating-Income for the three months ended in Mar. 2024 was 0.17.


Acrobiosystems Co Capex-to-Operating-Income Historical Data

The historical data trend for Acrobiosystems Co's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrobiosystems Co Capex-to-Operating-Income Chart

Acrobiosystems Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Income
Get a 7-Day Free Trial 0.66 0.11 0.32 1.72 0.93

Acrobiosystems Co Quarterly Data
Dec18 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.39 1.28 0.74 1.51 0.17

Competitive Comparison of Acrobiosystems Co's Capex-to-Operating-Income

For the Biotechnology subindustry, Acrobiosystems Co's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acrobiosystems Co's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acrobiosystems Co's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Acrobiosystems Co's Capex-to-Operating-Income falls into.



Acrobiosystems Co Capex-to-Operating-Income Calculation

Acrobiosystems Co's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-128.688) / 138.413
=0.93

Acrobiosystems Co's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-4.78) / 27.533
=0.17

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Acrobiosystems Co  (SZSE:301080) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Acrobiosystems Co Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Acrobiosystems Co's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Acrobiosystems Co (SZSE:301080) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Hongda North Road, 4th Floor, Building 4, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Acrobiosystems Co Ltd is a global brand focusing on protein technology, products and services in the development of biological drugs. It is committed to providing target antigens and other key reagents and related services required in the development of targeted therapeutic drugs.

Acrobiosystems Co (SZSE:301080) Headlines

No Headlines